Your browser doesn't support javascript.
loading
Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes.
Schouwenburg, Maartje G; Jochems, Anouk; Leeneman, Brenda; Franken, Margreet G; van den Eertwegh, Alfons J M; Haanen, John B A G; van Zeijl, Michiel C T; Aarts, Maureen J; van Akkooi, Alexander C J; van den Berkmortel, Franchette W P J; Blokx, Willeke A M; de Groot, Jan Willem B; Hospers, Geke A P; Kapiteijn, Ellen; Koornstra, Rutger H; Kruit, Wim H; Louwman, Marieke W J; Piersma, Djura; van Rijn, Rozemarijn S; Suijkerbuijk, Karijn P M; Ten Tije, Albert J; Vreugdenhil, Gerard; Wouters, Michel W J M; van der Hoeven, Jacobus J M.
Afiliação
  • Schouwenburg MG; Department of Medical Oncology, Leiden University Medical Centre.
  • Jochems A; Dutch Institute for Clinical Auditing, Leiden.
  • Leeneman B; Department of Medical Oncology, Leiden University Medical Centre.
  • Franken MG; Dutch Institute for Clinical Auditing, Leiden.
  • van den Eertwegh AJM; Department of Health Technology Assessment, Erasmus School of Health Policy and Management.
  • Haanen JBAG; Institute for Medical Technology Assessment, Erasmus University.
  • van Zeijl MCT; Department of Medical Oncology, VU University Medical Centre.
  • Aarts MJ; Departments of Medical Oncology.
  • van Akkooi ACJ; Department of Medical Oncology, Leiden University Medical Centre.
  • van den Berkmortel FWPJ; Dutch Institute for Clinical Auditing, Leiden.
  • Blokx WAM; Department of Medical Oncology, Maastricht University Medical Centre, Maastricht.
  • de Groot JWB; Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam.
  • Hospers GAP; Department of Internal Medicine, Zuyderland Medical Centre Geleen-Heerlen, Sittard-Geleen.
  • Kapiteijn E; Departments of Pathology.
  • Koornstra RH; Department of Medical Oncology, Isala, Zwolle.
  • Kruit WH; Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen.
  • Louwman MWJ; Department of Medical Oncology, Leiden University Medical Centre.
  • Piersma D; Medical Oncology, Radboud University Medical Centre, Nijmegen.
  • van Rijn RS; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam.
  • Suijkerbuijk KPM; Netherlands Comprehensive Cancer Organisation, Utrecht.
  • Ten Tije AJ; Department of Internal Medicine, Medisch Spectrum Twente, Enschede.
  • Vreugdenhil G; Department of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden.
  • Wouters MWJM; Department of Medical Oncology, University Medical Centre Utrecht Cancer Center, Utrecht.
  • van der Hoeven JJM; Departments of Medical Oncology.
Melanoma Res ; 28(4): 326-332, 2018 08.
Article em En | MEDLINE | ID: mdl-29750749
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas B-raf / Vemurafenib / Melanoma / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas B-raf / Vemurafenib / Melanoma / Antineoplásicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Melanoma Res Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article